Codeine Narcotic - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB506249540

Publication Date:

June 10, 2024

Pages:

135

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
The global market for Codeine Narcotic was estimated to be worth US$ 681.5 million in 2023 and is forecast to a readjusted size of US$ 965 million by 2030 with a CAGR of 5.1% during the forecast period 2024-2030
The Codeine Narcotic market is driven by the demand for effective pain management and the widespread use of codeine as an analgesic and antitussive medication. Codeine, a narcotic drug derived from opium, is prescribed to alleviate moderate to severe pain and suppress coughing. The prevalence of conditions causing pain, such as post-surgery recovery and chronic illnesses, contributes to market growth as healthcare professionals seek safe and accessible pain relief options. Moreover, codeine's relatively lower potential for abuse compared to other narcotics aligns with its continued medical use. However, the market also faces challenges, including the potential for misuse and addiction due to codeine's opioid properties, leading to regulatory controls and prescription limitations in various regions. Additionally, addressing patient education about codeine's potential risks and benefits, and ensuring proper dosing and monitoring can pose obstacles for healthcare providers. To succeed, pharmaceutical companies must focus on responsible prescribing practices, patient education, and addressing the challenges to ensure the appropriate use of codeine while providing effective pain management solutions that prioritize patient safety.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Codeine Narcotic, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Codeine Narcotic by region & country, by Type, and by Application.
The Codeine Narcotic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Codeine Narcotic.
麻豆原创 Segmentation
By Company
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Segment by Type:
Single-ingredient Codeine
Multi-ingredient Medications
Segment by Application
Narcotic Analgesic
Antitussive
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Codeine Narcotic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Codeine Narcotic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Codeine Narcotic in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Codeine Narcotic Product Introduction
1.2 Global Codeine Narcotic 麻豆原创 Size Forecast
1.2.1 Global Codeine Narcotic Sales Value (2019-2030)
1.2.2 Global Codeine Narcotic Sales Volume (2019-2030)
1.2.3 Global Codeine Narcotic Sales Price (2019-2030)
1.3 Codeine Narcotic 麻豆原创 Trends & Drivers
1.3.1 Codeine Narcotic Industry Trends
1.3.2 Codeine Narcotic 麻豆原创 Drivers & Opportunity
1.3.3 Codeine Narcotic 麻豆原创 Challenges
1.3.4 Codeine Narcotic 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Codeine Narcotic Players Revenue Ranking (2023)
2.2 Global Codeine Narcotic Revenue by Company (2019-2024)
2.3 Global Codeine Narcotic Players Sales Volume Ranking (2023)
2.4 Global Codeine Narcotic Sales Volume by Company Players (2019-2024)
2.5 Global Codeine Narcotic Average Price by Company (2019-2024)
2.6 Key Manufacturers Codeine Narcotic Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Codeine Narcotic Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Codeine Narcotic
2.9 Codeine Narcotic 麻豆原创 Competitive Analysis
2.9.1 Codeine Narcotic 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Codeine Narcotic Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Codeine Narcotic as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Single-ingredient Codeine
3.1.2 Multi-ingredient Medications
3.2 Global Codeine Narcotic Sales Value by Type
3.2.1 Global Codeine Narcotic Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Codeine Narcotic Sales Value, by Type (2019-2030)
3.2.3 Global Codeine Narcotic Sales Value, by Type (%) (2019-2030)
3.3 Global Codeine Narcotic Sales Volume by Type
3.3.1 Global Codeine Narcotic Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Codeine Narcotic Sales Volume, by Type (2019-2030)
3.3.3 Global Codeine Narcotic Sales Volume, by Type (%) (2019-2030)
3.4 Global Codeine Narcotic Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Narcotic Analgesic
4.1.2 Antitussive
4.1.3 Others
4.2 Global Codeine Narcotic Sales Value by Application
4.2.1 Global Codeine Narcotic Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Codeine Narcotic Sales Value, by Application (2019-2030)
4.2.3 Global Codeine Narcotic Sales Value, by Application (%) (2019-2030)
4.3 Global Codeine Narcotic Sales Volume by Application
4.3.1 Global Codeine Narcotic Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Codeine Narcotic Sales Volume, by Application (2019-2030)
4.3.3 Global Codeine Narcotic Sales Volume, by Application (%) (2019-2030)
4.4 Global Codeine Narcotic Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Codeine Narcotic Sales Value by Region
5.1.1 Global Codeine Narcotic Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Codeine Narcotic Sales Value by Region (2019-2024)
5.1.3 Global Codeine Narcotic Sales Value by Region (2025-2030)
5.1.4 Global Codeine Narcotic Sales Value by Region (%), (2019-2030)
5.2 Global Codeine Narcotic Sales Volume by Region
5.2.1 Global Codeine Narcotic Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Codeine Narcotic Sales Volume by Region (2019-2024)
5.2.3 Global Codeine Narcotic Sales Volume by Region (2025-2030)
5.2.4 Global Codeine Narcotic Sales Volume by Region (%), (2019-2030)
5.3 Global Codeine Narcotic Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Codeine Narcotic Sales Value, 2019-2030
5.4.2 North America Codeine Narcotic Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Codeine Narcotic Sales Value, 2019-2030
5.5.2 Europe Codeine Narcotic Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Codeine Narcotic Sales Value, 2019-2030
5.6.2 Asia Pacific Codeine Narcotic Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Codeine Narcotic Sales Value, 2019-2030
5.7.2 South America Codeine Narcotic Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Codeine Narcotic Sales Value, 2019-2030
5.8.2 Middle East & Africa Codeine Narcotic Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Codeine Narcotic Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Codeine Narcotic Sales Value
6.2.1 Key Countries/Regions Codeine Narcotic Sales Value, 2019-2030
6.2.2 Key Countries/Regions Codeine Narcotic Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Codeine Narcotic Sales Value, 2019-2030
6.3.2 United States Codeine Narcotic Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Codeine Narcotic Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Codeine Narcotic Sales Value, 2019-2030
6.4.2 Europe Codeine Narcotic Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Codeine Narcotic Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Codeine Narcotic Sales Value, 2019-2030
6.5.2 China Codeine Narcotic Sales Value by Type (%), 2023 VS 2030
6.5.3 China Codeine Narcotic Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Codeine Narcotic Sales Value, 2019-2030
6.6.2 Japan Codeine Narcotic Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Codeine Narcotic Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Codeine Narcotic Sales Value, 2019-2030
6.7.2 South Korea Codeine Narcotic Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Codeine Narcotic Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Codeine Narcotic Sales Value, 2019-2030
6.8.2 Southeast Asia Codeine Narcotic Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Codeine Narcotic Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Codeine Narcotic Sales Value, 2019-2030
6.9.2 India Codeine Narcotic Sales Value by Type (%), 2023 VS 2030
6.9.3 India Codeine Narcotic Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Taiji
7.1.1 Taiji Company Information
7.1.2 Taiji Introduction and Business Overview
7.1.3 Taiji Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Taiji Codeine Narcotic Product Offerings
7.1.5 Taiji Recent Development
7.2 Mallinckrodt
7.2.1 Mallinckrodt Company Information
7.2.2 Mallinckrodt Introduction and Business Overview
7.2.3 Mallinckrodt Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Mallinckrodt Codeine Narcotic Product Offerings
7.2.5 Mallinckrodt Recent Development
7.3 TEVA
7.3.1 TEVA Company Information
7.3.2 TEVA Introduction and Business Overview
7.3.3 TEVA Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
7.3.4 TEVA Codeine Narcotic Product Offerings
7.3.5 TEVA Recent Development
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Information
7.4.2 Johnson & Johnson Introduction and Business Overview
7.4.3 Johnson & Johnson Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Johnson & Johnson Codeine Narcotic Product Offerings
7.4.5 Johnson & Johnson Recent Development
7.5 Medreich
7.5.1 Medreich Company Information
7.5.2 Medreich Introduction and Business Overview
7.5.3 Medreich Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Medreich Codeine Narcotic Product Offerings
7.5.5 Medreich Recent Development
7.6 Sanofi Aventis
7.6.1 Sanofi Aventis Company Information
7.6.2 Sanofi Aventis Introduction and Business Overview
7.6.3 Sanofi Aventis Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Sanofi Aventis Codeine Narcotic Product Offerings
7.6.5 Sanofi Aventis Recent Development
7.7 Cipla
7.7.1 Cipla Company Information
7.7.2 Cipla Introduction and Business Overview
7.7.3 Cipla Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Cipla Codeine Narcotic Product Offerings
7.7.5 Cipla Recent Development
7.8 Hikma
7.8.1 Hikma Company Information
7.8.2 Hikma Introduction and Business Overview
7.8.3 Hikma Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Hikma Codeine Narcotic Product Offerings
7.8.5 Hikma Recent Development
7.9 Pharmaceutical Associates
7.9.1 Pharmaceutical Associates Company Information
7.9.2 Pharmaceutical Associates Introduction and Business Overview
7.9.3 Pharmaceutical Associates Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Pharmaceutical Associates Codeine Narcotic Product Offerings
7.9.5 Pharmaceutical Associates Recent Development
7.10 Novartis
7.10.1 Novartis Company Information
7.10.2 Novartis Introduction and Business Overview
7.10.3 Novartis Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Novartis Codeine Narcotic Product Offerings
7.10.5 Novartis Recent Development
7.11 Apotex
7.11.1 Apotex Company Information
7.11.2 Apotex Introduction and Business Overview
7.11.3 Apotex Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Apotex Codeine Narcotic Product Offerings
7.11.5 Apotex Recent Development
7.12 Mylan
7.12.1 Mylan Company Information
7.12.2 Mylan Introduction and Business Overview
7.12.3 Mylan Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Mylan Codeine Narcotic Product Offerings
7.12.5 Mylan Recent Development
7.13 Aristo Pharma GmbH
7.13.1 Aristo Pharma GmbH Company Information
7.13.2 Aristo Pharma GmbH Introduction and Business Overview
7.13.3 Aristo Pharma GmbH Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Aristo Pharma GmbH Codeine Narcotic Product Offerings
7.13.5 Aristo Pharma GmbH Recent Development
7.14 Lannett Company
7.14.1 Lannett Company Company Information
7.14.2 Lannett Company Introduction and Business Overview
7.14.3 Lannett Company Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Lannett Company Codeine Narcotic Product Offerings
7.14.5 Lannett Company Recent Development
7.15 Laboratoire Riva
7.15.1 Laboratoire Riva Company Information
7.15.2 Laboratoire Riva Introduction and Business Overview
7.15.3 Laboratoire Riva Codeine Narcotic Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Laboratoire Riva Codeine Narcotic Product Offerings
7.15.5 Laboratoire Riva Recent Development
8 Industry Chain Analysis
8.1 Codeine Narcotic Industrial Chain
8.2 Codeine Narcotic Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Codeine Narcotic Sales Model
8.5.2 Sales Channel
8.5.3 Codeine Narcotic Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.